Latest news
Hansoh Pharmaceutical Receives NMPA Approval for Clinical Trials of HS-10582 Tablets for Hypercholesterolemia and Dyslipidemia 1 – Minichart - MinichartMinichart · Fri, 07 Aug 2026 04:24:00 GMTOsteosarcoma ADCs break 40-year lull as SOT106 targets LRRC15 for trials - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 06 Aug 2026 21:01:00 GMTAvere Therapeutics - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 15:34:12 GMTGSK’s ADC prospects brighten further with Hansoh’s second Phase III triumph - Clinical Trials ArenaClinical Trials Arena · Wed, 29 Jul 2026 10:39:42 GMTGSK partner Hansoh reports another phase 3 win for priority ADC - Fierce BiotechFierce Biotech · Tue, 28 Jul 2026 12:20:00 GMTHansoh Pharma says osteosarcoma treatment drug meets primary endpoint in late stage trial - 101 WIXX101 WIXX · Tue, 28 Jul 2026 11:46:48 GMTGSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China - GSKGSK · Tue, 28 Jul 2026 07:00:00 GMTGSK’s licensor Hansoh Pharma announces positive new Ris-Rez data - The Pharma LetterThe Pharma Letter · Tue, 28 Jul 2026 07:00:00 GMT